191 related articles for article (PubMed ID: 2635834)
1. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma.
Sánchez Palacios A; Schamann Medina F; Lamas Rua-Figueroa A; Bosch Millares C; Ramos Santos S; García Marrero JA
Allergol Immunopathol (Madr); 1989; 17(6):323-9. PubMed ID: 2635834
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
3. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus.
García BE; Sanz ML; Wong E; Oehling A
Allergol Immunopathol (Madr); 1988; 16(6):379-83. PubMed ID: 3242375
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of oral immunotherapy in bronchial asthma caused by Dermatophagoides pternyssinus].
Pacor ML; Biasi D; Carletto A; Lunardi C
Recenti Prog Med; 1995 Dec; 86(12):489-91. PubMed ID: 8588080
[TBL] [Abstract][Full Text] [Related]
9. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
10. [Accelerated desensitization to Dermatophagoides pteronyssinus mites in children with asthma. Results of two years of immunotherapy].
Le Roux P; Le Luyer B
Allerg Immunol (Paris); 1991 Apr; 23(4):135-42. PubMed ID: 2069687
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
Zimmermann T; Mayer J
Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
[TBL] [Abstract][Full Text] [Related]
12. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
13. Topical nasal immunotherapy. Immunologic response of IgE in nasal secretion after immunotherapy with Dermatophagoides pteronyssinus.
Martín Mateos MA; Monferrer R; Muñoz López F
Allergol Immunopathol (Madr); 1990; 18(4):223-8. PubMed ID: 2264553
[TBL] [Abstract][Full Text] [Related]
14. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
15. Analysis of house dust mite-specific IgE, IgG4, and IgG antibodies during immunotherapy in asthmatic children.
Lin KL; Wang SY; Hsieh KH
Ann Allergy; 1991 Jul; 67(1):63-9. PubMed ID: 1859043
[TBL] [Abstract][Full Text] [Related]
16. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
Tari MG; Mancino M; Monti G
Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
[TBL] [Abstract][Full Text] [Related]
18. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
20. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
